Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

McGill University

$67,746.00

Smart Mandibular Advancement Device (MAD) for sleep monitoring

FY 2019-20

Summary
Obstructive Sleep Apnea (OSA) is a condition that affects 3-7% of the general population and 40% of patients with obesity. Generally, diagnosis of sleep apnea and determining the efficacy OSA treatment involve overnight monitoring of breathing and other body functions during sleep at labs. However, due to the limited capacity of sleep labs in Canada there is a long waiting to do sleep studies. Mandibular Advancement Device (MAD) is designed to treat OSA. The aim of this project is to design, develop and evaluate a cost effective intraoral smart MAD integrating a multi sensor platform and EEG electrodes. The smart MAD will allow intraoral measurement of physiological parameters such as blood oxygen saturation, EEG signal, heart and breathing rate as well as accelerometry to detect sleep latency, onset and duration. The platform will have potential to document sleep patterns from home and evaluate the effectiveness of MAD treatment on time. There are currently no intelligent MADs on the market. Providing patients with such a device should help iMD Research acquire a projected 10% of Quebec MAD market share within the first 24 months of production. Due to the physiological monitoring feature of the MAD, Metropole Dentaire will be able to treat a much larger portion of the OSA population expected to double within 2 years of initial production. The healthcare providers in Canada will be able to document patient's sleep on a regular basis and evaluate the effectiveness of the MAD treatment without sending them to sleep labs. Thus, it will lower the heavy demand on sleep labs and lower the treatment cost in Canada. Documenting the sleep data on patients will help advance the sleep apnea research and treatment in Canada. In the future, the multi sensing platform and the EEG electrodes will be embedded in other intraoral wearable devices to diagnose sleep apnea and other health conditions from home. This will help diagnose sleep apnea faster and reduce the number of untreated sleep apnea patients, which, in turn, will reduce the economic loss related to untreated sleep apnea. Additionally, this will reduce the wait times in Canadian healthcare system for health condition diagnosis.
Program
Collaborative Research and Development Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
531526-2018
Name nom
Bhadra, Sharmistha
Department département
Electrical and Computer Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
67746
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2519
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Microelectronics
Research subject fr
Microélectronique
Installment
inst:2 - 2
Partie
2
Nb partie
2
Application title
Smart Mandibular Advancement Device (MAD) for sleep monitoring
Keyword
NSERC
Application summary
Obstructive Sleep Apnea (OSA) is a condition that affects 3-7% of the general population and 40% of patients with obesity. Generally, diagnosis of sleep apnea and determining the efficacy OSA treatment involve overnight monitoring of breathing and other body functions during sleep at labs. However, due to the limited capacity of sleep labs in Canada there is a long waiting to do sleep studies. Mandibular Advancement Device (MAD) is designed to treat OSA. The aim of this project is to design, develop and evaluate a cost effective intraoral smart MAD integrating a multi sensor platform and EEG electrodes. The smart MAD will allow intraoral measurement of physiological parameters such as blood oxygen saturation, EEG signal, heart and breathing rate as well as accelerometry to detect sleep latency, onset and duration. The platform will have potential to document sleep patterns from home and evaluate the effectiveness of MAD treatment on time. There are currently no intelligent MADs on the market. Providing patients with such a device should help iMD Research acquire a projected 10% of Quebec MAD market share within the first 24 months of production. Due to the physiological monitoring feature of the MAD, Metropole Dentaire will be able to treat a much larger portion of the OSA population expected to double within 2 years of initial production. The healthcare providers in Canada will be able to document patient's sleep on a regular basis and evaluate the effectiveness of the MAD treatment without sending them to sleep labs. Thus, it will lower the heavy demand on sleep labs and lower the treatment cost in Canada. Documenting the sleep data on patients will help advance the sleep apnea research and treatment in Canada. In the future, the multi sensing platform and the EEG electrodes will be embedded in other intraoral wearable devices to diagnose sleep apnea and other health conditions from home. This will help diagnose sleep apnea faster and reduce the number of untreated sleep apnea patients, which, in turn, will reduce the economic loss related to untreated sleep apnea. Additionally, this will reduce the wait times in Canadian healthcare system for health condition diagnosis.